Xcout IntelFoghorn Therapeutics Inc. competitors & alternatives
The 12 closest competitors and alternatives to Foghorn Therapeutics Inc. among biotech companies — ranked by similarity to what Foghorn Therapeutics Inc. actually does, not by market-cap band.
Subscribe to see Foghorn Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Foghorn Therapeutics Inc.
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Foghorn Therapeutics Inc. at a glance
Foghorn Therapeutics Inc. is a biotech company headquartered in Watertown, United States, founded in 2016. It is publicly listed (FHTX) with a market capitalisation of $118.8M. Xcout tracks 31 named people at Foghorn Therapeutics Inc., including Adrian H. Gottschalk (President, Chief Executive Officer & Director).
Foghorn Therapeutics Inc. leadership
- Adrian H. GottschalkPresident, Chief Executive Officer & Director
- Adrian GottschalkPresident & CEO
- Karin HellsvikChief of Staff to the CEO, VP, Head of Corporate Affairs, Investor Relations & Operations
- Ryan D MaynardChief Financial Officer
- Ryan MaynardChief Financial Officer
- Steven F. BellonChief Scientific Officer
25 more named people on record for Foghorn Therapeutics Inc., with roles, board committees and tenure — see the full roster →
Top 12 Foghorn Therapeutics Inc. competitors
Ranked by semantic similarity — how close each company is to Foghorn Therapeutics Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Similar biotech company
Metaphore Biotechnologies, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, operating as part of Flagship Pioneering. The company focuses on therapeutic design, leveraging AI and machine learning technologies for drug discovery and development.
Biotechnology
Dewpoint Therapeutics is an integrated drug discovery platform company headquartered in Boston, Massachusetts. The firm leverages advanced biotechnology to translate condensate biology into novel medicines for various therapeutic areas.
Biotechnology
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Similar biotech company
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Biotechnology
ProFound Therapeutics is a biotechnology company founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Headquartered in Cambridge, Massachusetts, the company is pioneering the exploration of the expanded human proteome.
Biotechnology
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
Similar biotech company
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Biotechnology
Superluminal Medicines is a generative biology and chemistry company headquartered in Boston, Massachusetts, focused on drug discovery and development.
Biotechnology
LifeMine Therapeutics is a privately held biotechnology company founded in 2017 with headquarters in Watertown, Massachusetts, and an additional location in Switzerland. The company leverages genomic data to accelerate the discovery and development of novel small-molecule medicines.
Similar biotech company
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Foghorn Therapeutics Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Foghorn Therapeutics Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →